Parkinson’s disease affects 7 to 10 million people worldwide and is the second most frequent neurodegenerative disease after Alzheimer’s. Significant advances have been made over the past two decades both in the understanding of the mechanisms underlying the disease and in patient management.

     This session is designed as an interface between clinicians and researchers. Its aim is to provide updates on Parkinson’s disease from pathophysiology to treatment. The lectures are all given by leaders in their respective fields. Being organized by the ICN PhD program, this session is primarily aimed for students (Master, PhD, Med School, Neurology Residents).

     However, everyone is more than welcome to attend.


  9:00  Welcome / coffee

  9:30  Clinical presentation : Jean-Philippe Azulay

10:10  Pathopsysiology : Lydia Kerkerian-Le Goff

10:40  Etiological hypotheses / Epidemiology : Wassilio Meissner

11:20  Cell death mechanisms : Etienne Hirsch

12:00  Animal models : outputs and limitations : Paolo Gubellini

12:30  Questions

13:00  Lunch

14:30  Preclinical pharmacology/ novel therapeutic targets  : Marianne Amalric

15:10  Clinical pharmacology and trials : Olivier Rascol

16:00  Coffee break

16:30  Functional neurosurgery (Deep brain stimulation) : Alex Eusebio

17:10  Cell and gene-based therapies : Stéphane Palfi

17:50  Questions 




Amphithéâtre HA1 de l’hôpital Timone Adulte - RdC

264 rue Saint-Pierre


Online user: 1